Vaccines

22 Aug 2011 Isconova and Genocea expand collaboration
22 Aug 2011 Immune Response BioPharma Reports NeuroVax MS Vaccine Increased Results with Women Taking Estrogen
18 Aug 2011 Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
15 Aug 2011 Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccine
12 Aug 2011 Advaxis Completes Pre-IND Meeting for ADXS-PSA
12 Aug 2011 TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application
12 Aug 2011 New Tuberculosis Vaccine Enters Phase IIb Proof-of-Concept Trial in People Living with HIV in Senegal and South Africa
10 Aug 2011 Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies
05 Aug 2011 New Hope for Immune Therapy for Children and Young Adults With Type 1 Diabetes: Founder of Orban Biotech's Landmark Findings for Abatacept Published in The Lancet
03 Aug 2011 International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
03 Aug 2011 NanoBio Secures Novel Antigen Source for its Intranasal RSV Vaccine
03 Aug 2011 Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine (PCV)
01 Aug 2011 AbD Serotec and Merck Sign License Agreement for Use of HuCAL GOLD in Vaccine Research
26 Jul 2011 VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA
21 Jul 2011 Vical Reports Successful Nonclinical Results With Vaxfectin(R) Adjuvant
21 Jul 2011 BioSante Pharmaceuticals Signs Melanoma Vaccine License
20 Jul 2011 Dynavax Phase 3 Demonstrates Superiority and Safety of HEPLISAV(TM) vs. Engerix-B(R)
20 Jul 2011 Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Candidate, AEZS-120
18 Jul 2011 Functional Cure in Non-Human Primates Achieved With Simian Version of VIRxSYS' HIV Vaccine VRX1273
18 Jul 2011 SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial
18 Jul 2011 MEDIMMUNE SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR QUADRIVALENT SEASONAL NASAL SPRAY INFLUENZA VACCINE
18 Jul 2011 Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial
15 Jul 2011 Inovio Pharmaceuticals Demonstrates T Cell Immune Response Durability with Fourth Dose of Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
14 Jul 2011 Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
14 Jul 2011 Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top